Purchase Order 75N94019P00775

This is a $3,273,876.00 cost-plus-fixed-fee Delivery Order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL) for the characterization of the pharmacokinetic/pharmacodynamic (PK/PD) profile of a candidate HIV prevention drug in rhesus macaques. The contract is part of the Comprehensive Resources for HIV Microbicides and Biomedical Prevention...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Aalto Bio Reagents Limited, a for-profit limited liability company. The award, valued at $9,204.00, is for the purchase of 13 vials of 2 mg each of "AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120" at $728.00 per vial. The contract has a firm fixed price and an ultimate completion date of March 31, 2014. The...

Southern Research Institute was awarded a $749,998 cost-plus-fixed-fee delivery order against the In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). Under this delivery order, Southern Research will carry out activities to optimize, develop, and synthesize lead anti-HIV candidates and analogs, including resynthesis, acquisition, or...

This is a $227,601 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Preclinical Services for HIV Therapeutics Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The purpose is to conduct in vitro screening of interventional agents in high throughput screening (HTS) formats to identify HIV inhibitors. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization. Two subcontractors are...

The U.S. Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,150.00 cost-plus-fixed-fee delivery order contract to Southern Research Institute for assay development and validation to identify and evaluate the efficacy of anti-HIV therapeutics and topical microbicides. This contract is part of the agency's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. Southern...

This firm fixed price purchase order for $197,737 was awarded by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to Bioqual, Inc. to conduct a 190-day in vivo study of Nipamovir in rhesus macaques. Under the contract, Bioqual will acquire and maintain infected monkeys, administer the test compound according to an agreed-upon protocol, collect samples and measurements, provide biweekly status reports and a draft final report to the NIDDK...

This contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $124,693.14 firm fixed price contract is for HIV-1 TEST V2.0 PN#5212308190, with a completion date of March 6, 2020. The contract was not set aside for any particular business type. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and...

This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for $1,356,494.24. The contract is for statistical and pharmacometric modeling support to aid in the development of HIV non-vaccine biomedical prevention products. The contract is part of NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program, which funds product development initiatives in this area. ABL,...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Accelevir Diagnostics LLC, a woman-owned small business. The contract, valued at $299,975.00, is for the company to adapt its Intact Proviral DNA Assay (IPDA) to measure latent HIV-1 for individuals with the CRF-1_AE genetic subtype of the virus. This contract is part of NIAID's Small Business Innovation Research (SBIR)...

This federal contract award is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The prime contractor is Southern Research Institute, a non-profit organization that provides advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology. The contract, with a potential value of $494,934.25, is...